According to Baidu Encyclopedia, Harbin Pharmaceutical Group Co., Ltd. is a state-owned joint venture. It has two public companies listed on the Shanghai Stock Exchange (namely Harbin Pharmaceutical Group Co., Ltd. and Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.) and 27 wholly-owned, holding and shareholding companies. There are more than 20,000 employees with a registered capital of 3.7 billion yuan and total assets of11900 million yuan. Harbin Pharmaceutical Group integrates pharmaceutical manufacturing, trade and scientific research, and its main business covers seven major industrial fields, including antibiotics, chemical pharmaceutical preparations, over-the-counter drugs and health food, traditional Chinese medicine, bioengineering drugs, animal vaccines and veterinary drugs, and pharmaceutical circulation. According to the above information, Harbin Pharmaceutical Group is a state-owned joint venture, so it is a state-owned enterprise.